The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. H. (1980) · Nature · doi:10.1038/286264a0 · Cited by 2,060
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., & Dey, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80402-x · Cited by 1,430
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Lewis (1990) · doi:10.1056/nejm199009063231006 · Cited by 1,200
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
New insights into the mode of action of anti-inflammatory drugs
Vane, J. R., & Botting, R. M. (1995) · Inflammation Research · doi:10.1007/bf01630479 · Cited by 838
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
Dixon, R. A. F., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., & Miller, D. K. (1990) · Nature · doi:10.1038/343282a0 · Cited by 774
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Miller, T. A. (1983) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1983.245.5.g601 · Cited by 589
Zhang, X., Schwarz, E. M., Young, D. A., Puzas, J. E., Rosier, R. N., & O’Keefe, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215681 · Cited by 577
Cyclo-Oxygenase 2 Function Is Essential for Bone Fracture Healing
Simon, A. M., Manigrasso, M. B., & O'Connor, J. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.963 · Cited by 530
Identification and isolation of a membrane protein necessary for leukotriene production
Miller, D. K., Gillard, J. W., Vickers, P. J., Sadowski, S., Léveillé, C., Mancini, J. A., Charleson, P., Dixon, R. A. F., Ford-Hutchinson, A. W., Fortin, R., et al. (1990) · Nature · doi:10.1038/343278a0 · Cited by 459
Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Annual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
LIU, X. H., KIRSCHENBAUM, A., YAO, S., LEE, R., HOLLAND, J. F., & LEVINE, A. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67321-1 · Cited by 363
Anovulation in Cyclooxygenase-2-Deficient Mice Is Restored by Prostaglandin E2 and Interleukin-1β*
Davis, B. J., Lennard, D. E., Lee, C. A., Tiano, H. F., Morham, S. G., Wetsel, W. C., & Langenbach, R. (1999) · Endocrinology · doi:10.1210/endo.140.6.6715 · Cited by 352
Wallace, J. L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K. A., & MacNaughton, W. K. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70370-1 · Cited by 336
Rouzer, C. A., Ford-Hutchinson, A. W., Morton, H. E., & Gillard, J. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40034-3 · Cited by 314
Attiga, F. A., Fernández, P. M., Weeraratna, A. T., Manyak, M. J., & Patierno, S. R. (2000) · PubMed · Cited by 310
Leukotriene B: a potential mediator of inflammation
Smith, M. J. H., Ford-Hutchinson, A. W., & Bray, M. A. (1980) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1980.tb12985.x · Cited by 298
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Fiorucci, S., Meli, R., Bucci, M., & Cirino, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00747-x · Cited by 285
Notoya, K., Jovanovic, D. V., Reboul, P., Martel-Pelletier, J., Mineau, F., & Pelletier, J.-P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3402 · Cited by 284
Self-citationRenal complications of nonsteroidal anti-inflammatory drugs
Schlondorff, D. (1993) · Kidney International · doi:10.1038/ki.1993.293 · Cited by 279
Serhan, C. N. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00001-4 · Cited by 241
Knapp, H. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232506 · Cited by 239
Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., & Fiore, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2660 · Cited by 215
Leukotriene B4: An inflammatory mediator In vivo
Bray, M. A., Ford‐Hutchinson, A. W., & Smith, M. J. H. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90036-8 · Cited by 213
Clish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Gronert, K., Gewirtz, A., Madara, J. L., & Serhan, C. N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1285 · Cited by 207
Hassan, B. S., Doherty, S. A., Mockett, S., & Doherty, M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.5.422 · Cited by 205
Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors
Katori, M., & Majima, M. (2000) · Inflammation Research · doi:10.1007/s000110050605 · Cited by 193
Jouzeau, J.-Y., Terlain, B., Abid, A., Nédélec, E., & Netter, P. (1997) · Drugs · doi:10.2165/00003495-199753040-00003 · Cited by 192
(2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00861.x · Cited by 187
Rainsford, K. D. (1987) · Inflammation Research · doi:10.1007/bf01966502 · Cited by 169
Cyclooxygenase-2–selective inhibitors impair glomerulogenesis and renal cortical development
Kömhoff, M., Wang, J.-L., Cheng, H.-F., Langenbach, R., Mckanna, J. A., Harris, R. C., & Breyer, M. D. (2000) · Kidney International · doi:10.1016/s0085-2538(15)46757-2 · Cited by 165
Hudson, N., Balsitis, M., Everitt, S., & Hawkey, C. J. (1993) · Gut · doi:10.1136/gut.34.6.742 · Cited by 155
Sousa, A. R., Pfister, R., Christie, P. E., Lane, S. J., Nasser, S. M., Schmitz-Schumann, M., & Lee, T. H. (1997) · Thorax · doi:10.1136/thx.52.11.940 · Cited by 155
Crofford, L. J., Oates, J. C., McCune, W. J., Gupta, S., Kaplan, M. J., Catella-Lawson, F., Morrow, J. D., McDonagh, K. T., & Schmaier, A. H. (2000) · Arthritis & Rheumatism · Cited by 152
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
Serhan, C. N., & Oliw, E. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13375 · Cited by 151
Designing therapeutically effective 5-lipoxygenase inhibitors
McMillan, R. M., & Walker, E. R. H. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90100-k · Cited by 147
5-Lipoxygenase: A Target for Antiinflammatory Drugs Revisited
Steinhilber, D. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220207211259 · Cited by 146
Cyclooxygenase 2 and the kidney
Breyer, M. D., & Harris, R. C. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200101000-00014 · Cited by 145
Wallace, J. L., Chapman, K., & McKnight, W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702420 · Cited by 124
Hawkey, C., Dubé, L. M., Rountree, L., Linnen, P., & Lancaster, J. F. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041232 · Cited by 114
Li, J., Burr, D. B., & Turner, C. H. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-1025-y · Cited by 112
Jovanović, D., Fernandes, J., Martel‐Pelletier, J., Jolicoeur, F.-C., Reboul, P., Laufer, S., Tries, S., & Pelletier, J. (2001) · Arthritis & Rheumatism · Cited by 104
Self-citationContribution of cyclooxygenase‐2 to liver regeneration after partial hepatectomy
Casado, M., Callejas, N. A., Rodrigo, J., Zhao, X., Dey, S. K., Boscá, L., & Martín‐Sanz, P. (2001) · The FASEB Journal · doi:10.1096/fj.01-0158fje · Cited by 103
He, W. W., Pelletier, J., Martel‐Pelletier, J., et al. (2002) · PubMed · Cited by 88
Self-citationBelvisi, M. G., Saunders, M., Yacoub, M. H., & Mitchell, J. A. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702104 · Cited by 87
Inhibitors of cyclooxygenase-2 and 5-lipoxygenase
(1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.9.1041 · Cited by 86
The Molecular Biology and Regulation of 5-Lipoxygenase
Rådmark, O. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-3 · Cited by 82
Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
Weinblatt, M. E., Jm, K., Js, C., Helfgott, S. M., Al, M., Petrillo, G. F., Henson, B. A. B., Rubin, P. D., & Sperling, R. I. (1992) · PubMed · Cited by 81
Wallace, J. L., McKnight, G. W., Keenan, C. M., et al. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90331-t · Cited by 74
Kawai, S. (1998) · Inflammation Research · doi:10.1007/s000110050291 · Cited by 73
Paredes, Y., Massicotte, F., Pelletier, J., Martel‐Pelletier, J., Laufer, S., & Lajeunesse, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10357 · Cited by 73
Self-citationLeukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage
Rainsford, K. D. (1993) · Inflammation Research · doi:10.1007/bf01972709 · Cited by 68
Sala, A., & Folco, G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4865 · Cited by 67
Enhanced renal leukotriene production in murine lupus: Role of lipoxygenase metabolites
Spurney, R. F., Ruiz, P., Pisetsky, D. S., & Coffman, T. M. (1991) · Kidney International · doi:10.1038/ki.1991.12 · Cited by 64
Sala, A., Aliev, G. M., Rossoni, G., Berti, F., Buccellati, C., Burnstock, G., Folco, G. C., & Maclouf, J. (1996) · Blood · doi:10.1182/blood.v87.5.1824.1824 · Cited by 61
Therapeutic Roles Of Selective Cox-2 Inhibitors
Vane, J. R., & Botting, R. M. (2001) · Medical Entomology and Zoology · Cited by 58
Sala, A., Rossoni, G., Buccellati, C., Berti, F., Folco, G. C., & Maclouf, J. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13943.x · Cited by 58
Leukotrienes: lipid bioeffectors of inflammatory reactions.
Sala, A., Zarini, S., & Bolla, M. (1998) · PubMed · Cited by 57
Ottino, P., & Bazán, H. E. P. (2001) · Current Eye Research · doi:10.1076/ceyr.23.2.77.5471 · Cited by 51
ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury
Wallace, J. L., Carter, L., McKnight, W., Tries, S., & Laufer, S. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90814-1 · Cited by 48
Leukotriene B4 potentiates colonic ulceration in the rat
Wallace, J. L., & Keenan, C. M. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540411 · Cited by 47
Collawn, C., Rubin, P., Perez, N., Bobadilla, J., Cabrera, G., Reyes, E., Borovoy, J., & Kershenobich, D. (1992) · PubMed · Cited by 47
Discovery and development of ML3000
Laufer, S. (2001) · Inflammopharmacology · doi:10.1163/156856001300248371 · Cited by 46
Rainsford, K. D., Ying, C., & Smith, F. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05875.x · Cited by 44
Horizoe, T., Nagakura, N., Chiba, K., Shirota, H., Shinoda, M., Kobayashi, N., Numata, H., Okamoto, Y., & Kobayashi, S. (1998) · Inflammation Research · doi:10.1007/s000110050347 · Cited by 33
Antiarthritic profile of BF-389 — A novel anti-inflammatory agent with low ulcerogenic liability
Wong, S., Lee, S. J., Frierson, M. R., Proch, J., Miskowski, T. A., Rigby, B. S., Schmolka, S. J., Naismith, R. W., Kreutzer, D. C., & Lindquist, R. R. (1992) · Inflammation Research · doi:10.1007/bf01987895 · Cited by 29
Waldman, S. A., Vitow, C., Osborne, B., Gillen, L. P., Argentieri, D. C., Wong, F. A., Smith, I. L., Chow, A. T., Misiti, J., & Bjornsson, T. D. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb05033.x · Cited by 22
Cited by
Ali, B. H., Blunden, G., Tanira, M. O., & Nemmar, A. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.085 · Cited by 1,588
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Kaempferol and inflammation: from chemistry to medicine
Devi, K. P., Malar, D. S., Nabavi, S. F., Sureda, A., Xiao, J., Nabavi, S. M., & Daglia, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.002 · Cited by 619
Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin
Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., Darabi, R., Shakeri‐Zadeh, A., Shahriari, M., Reiter, R. J., Ghaznavi, H., & Mehrzadi, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12362 · Cited by 344
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., Qu, W., & Sun, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00017 · Cited by 281
Metadata
- Authors
- Martel-Pelletier, J., Lajeunesse, D., Reboul, P., & Pelletier, J.-P.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 62
- Issue
- 6
- Pages
- 501-509
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2115899272
- Cited by
- 439
- References
- 79
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.